Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Harrison

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Neurology|September 4, 2021
COVID-19 mRNA vaccination leading to CNS inflammation: a case seriesMahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz, et al.
Frontiers in Neurology|December 18, 2023
Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovationJiwon Oh, Laura Airas, Daniel Harrison, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 3, 2018
"ALS reversals": demographics, disease characteristics, treatments, and co-morbiditiesDaniel Harrison, Paul Mehta, Michael A van Es, et al.
Physics in Medicine and Biology|February 22, 2014
A multi-source inverse-geometry CT system: initial results with an 8 spot x-ray source arrayJongduk Baek, Bruno De Man, Jorge Uribe, et al.
Neurology. Education|February 10, 2025
Education Research: Neurologic Education in Nurse Practitioner Programs: Results of a National Needs Assessment SurveyKathryn Swider, Calli Cook, Justin DiLibero, et al.
Neurology. Education|May 12, 2025
Erratum: Education Research: Neurologic Education in Nurse Practitioner ProgramsKathryn Swider, Calli Cook, Justin DiLibero, et al.
Investigational New Drugs|November 5, 2016
Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studiesAlexandra Tyulyandina, Daniel Harrison, Wei Yin, et al.
Royal Society Open Science|May 19, 2021
Large-scale interventions may delay decline of the Great Barrier ReefScott A Condie, Kenneth R N Anthony, Russ C Babcock, et al.
Cancers|December 24, 2021
Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma CellsDavid King, Harriet E D Southgate, Saskia Roetschke, et al.
Oncotarget|January 12, 2023
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastomaDavid King, Xiao Dun Li, Gilberto S Almeida, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neurology|September 4, 2021
COVID-19 mRNA vaccination leading to CNS inflammation: a case seriesMahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz, et al.
Frontiers in Neurology|December 18, 2023
Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovationJiwon Oh, Laura Airas, Daniel Harrison, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 3, 2018
"ALS reversals": demographics, disease characteristics, treatments, and co-morbiditiesDaniel Harrison, Paul Mehta, Michael A van Es, et al.
Physics in Medicine and Biology|February 22, 2014
A multi-source inverse-geometry CT system: initial results with an 8 spot x-ray source arrayJongduk Baek, Bruno De Man, Jorge Uribe, et al.
Neurology. Education|February 10, 2025
Education Research: Neurologic Education in Nurse Practitioner Programs: Results of a National Needs Assessment SurveyKathryn Swider, Calli Cook, Justin DiLibero, et al.
Neurology. Education|May 12, 2025
Erratum: Education Research: Neurologic Education in Nurse Practitioner ProgramsKathryn Swider, Calli Cook, Justin DiLibero, et al.
Investigational New Drugs|November 5, 2016
Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studiesAlexandra Tyulyandina, Daniel Harrison, Wei Yin, et al.
Royal Society Open Science|May 19, 2021
Large-scale interventions may delay decline of the Great Barrier ReefScott A Condie, Kenneth R N Anthony, Russ C Babcock, et al.
Cancers|December 24, 2021
Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma CellsDavid King, Harriet E D Southgate, Saskia Roetschke, et al.
Oncotarget|January 12, 2023
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastomaDavid King, Xiao Dun Li, Gilberto S Almeida, et al.
Pageof 4